bluuebunny/crossref_metadata_2025_split huggingface dataset:
Crystal structure of Tutton’s salts, Cs2[MII(H2O)6](SO4)2, MII = Mg, Mn, Fe, Co, Ni, Zn
Authors: Euler H. , Barbier B. , Meents A. , Kirfel A. 
Published: September 2014

Abstract Cs2H12MgO14S2, monoclinic, P121/a1 (No. 14), a = 9.338(2) Å, b = 12.849(4) Å, c = 6.361(2) Å, β = 107.07(2)°, V = 729.6 Å3, Z = 2, Rgt(F) = 0.017, wRref(F2) = 0.041, T = 293 K. Cs2H12MnO14S2, monoclinic, P121/a1 (No. 14), a = 9.418(3) Å, b = 12.963(2) Å, c = 6.386(3) Å, β = 107.17(4)°, V = 744.9 Å3, Z = 2, Rgt(F) = 0.017, wRref(F2) = 0.030, T = 293 K. Cs2FeO14H12S2, monoclinic, P121/a1 (No. 14), a = 9.357(2) Å, b = 12.886(2) Å, c = 6.381(1) Å, β = 106.94(1)°, V = 736.0 Å3, Z = 2, Rgt(F) = 0.015, wRref(F2) = 0.030, T = 293 K. CoCs2H12O14S2, monoclinic, P121/a1 (No. 14), a = 9.318(1) Å, b = 12.826(3) Å, c = 6.3650(9) Å, β = 107.13(1)°, V = 727.0 Å3, Z = 2, Rgt(F) = 0.021, wRref(F2) = 0.049, T = 293 K. Cs2H12NiO14S2, monoclinic, P121/a1 (No. 14), a = 9.259(2) Å, b = 12.767(2) Å, c = 6.358(1) Å, β = 107.00(2)°, V = 718.7 Å3, Z = 2, Rgt(F) = 0.014, wRref(F2) = 0.027, T = 293 K. Cs2H12O14S2Zn, monoclinic, P121/a1 (No. 14), a = 9.314(2) Å, b = 12.817(2) Å, c = 6.369(2) Å, β = 106.94(2)°, V = 727.3 Å3, Z = 2, Rgt(F) = 0.015, wRref(F2) = 0.033, T = 293 K.
Crystal structure of lanthanum borocarbide, La5B4C5–x (x = 0.15)
Authors: Mattausch Hj. , Babizhetskyy V. , Simon A. 
Published: September 2014

Abstract B8C9.71La10, orthorhombic, Pna21 (No. 33), a = 24.657(1) Å, b = 8.6051(5) Å, c = 8.6540(7) Å, V = 1836.2 Å3, Z = 4, Rgt(F) = 0.039, wRref(F2) = 0.106, T = 293 K.
Crystal structure of 9-benzyl-6-ethoxy-7-ethyl-2-phenyl-7,9- dihydropurin-8-one, C22H22N4O2
Authors: Euler H. , Kirfel A. , Bauer A. , Müller C. E. 
Published: September 2014

Abstract C22H22N4O2, monoclinic, C12/c1 (No. 15), a = 22.44(1) Å, b = 7.878(2) Å, c = 23.295(6) Å, β = 97.75(3)°, V = 4080.9 Å3, Z = 8, Rgt(F) = 0.045, wRref(F2) = 0.131, T = 295 K.
Crystal structure of (2-picoloylcarbonyl)thiosemicarbazone, C7H10N4O2S
Authors: Wu W.-S. , Feng Y.-L. 
Published: September 2014

Abstract C7H10N4O2S, orthorhombic, Pbca (No. 61), a = 12.1705(9) Å, b = 7.421(2) Å, c = 22.7584(5) Å, V = 2055.3 Å3, Z = 8, Rgt(F) = 0.033, wRref(F2) = 0.075, T = 293 K.
Crystal structure of tris(nitrato-O,O′)bis(1,10-phenanthroline-N,N′)- cerium(III), Ce(NO3)3(C12H8N2)2
Authors: Lin Q.-Y. , Feng Y.-L. 
Published: September 2014

Abstract C24H16CeN7O9, monoclinic, C12/c1 (No. 15), a = 11.162(2) Å, b = 18.070(4) Å, c = 13.102(3) Å, β = 100.56(3)°, V = 2597.9 Å3, Z = 4, Rgt(F) = 0.021, wRref(F2) = 0.056, T = 293 K.
Crystal structure of diaqua-monodimethylglycine-hexakis(μ2-dimethylglycine- O:O)-μ3-oxo-triiron(III) heptanitrate—water—dimethylgycine solvate (1:4:0.63), Fe3O(C4H9NO2)7(H2O)2(NO3)7 · 4H2O · 0.63C4H9NO2
Authors: Ramos Silva M. , Matos Beja A. , Paixão J. A. , Martin-Gil J. 
Published: September 2014

Abstract C30.20H80.60Fe3N14.30O43.26, triclinic, P1̅ (No. 2), a = 12.424(6) Å, b = 16.565(5) Å, c = 17.627(3) Å, α = 90.59(4)°, β = 101.48(4)°, γ = 108.97(4)°, V = 3351.1 Å3, Z = 2, Rgt(F) = 0.070, wRref(F2) = 0.261, T = 293 K.
Crystal structure of imidazolium decanedioate, C18H31N2O6
Authors: Garbarczyk J. , Pogorzelec-Glaser K. 
Published: September 2014

Abstract C18H31N2O6, triclinic, P1̅(No. 2), a = 8.8249(8) Å, b = 8.992(2) Å, c = 12.897(2) Å, α = 95.22(1)°, β = 92.91(1)°, γ = 94.62(1)°, V = 1014.1 Å3, Z = 2, Rgt(F) = 0.042, wRref(F2) = 0.124, T = 293 K.
Crystal structure of tetraguanidinium dioxo-tetraperoxo-μ-tartratodimolybdate(VI) dihydrate, (CN3H6)4[Mo2O2(O2)4(C4H2O6)] · 2H2O
Authors: Tinant B. , Bayot D. , Devillers M. 
Published: September 2014

Abstract C16H60Mo4N24O36, orthorhombic, Pna21 (No. 33), a = 29.387(9) Å, b = 9.979(3) Å, c = 19.062(5) Å, V = 5590.0 Å3, Z = 4, Rgt(F) = 0.094, wRref(F2) = 0.264, T = 293 K.
Crystal structure of sodium caesium tetrahydrogen-tetraborate tetrahydrate, NaCs[B4O5(OH)4] · 4H2O
Authors: Zhou J.-G. , ZhaoI F.-Y. , Xia S.-P. , Yang L. , Lu Y. , Wang J.-J. , Gao S.-Y. 
Published: September 2014

Abstract B4CsH12NaO13, monoclinic, P121/c1 (no. 14), a = 8.240(1) Å, b = 11.493(1) Å, c = 12.900(2) Å, β = 92.11(1)°, V = 1220.8 Å3, Z = 4, Rgt(F) = 0.023, wRref(F2) = 0.056, T = 296 K.
Crystal structure of 1,10-phenanthrolinecopper(II) bis(dihydrogen-1,3,5- benzenetricarboxylate), Cu(C12H8N2)(C9H5O6)2
Authors: Hu M.-L. , Shi Q. , Xiao H.-P. , Chen F. 
Published: September 2014

Abstract C30H18CuN2O12, monoclinic, C12/c1 (no. 15), a = 9.9829(8) Å, b = 15.605(1) Å, c = 16.967(1) Å, β = 97.154(1)°, V = 2622.4 Å3, Z = 4, Rgt(F) = 0.028, wRref(F2) = 0.082, T = 273 K.
Crystal structure of bis[triaqua(2,2-bipyridine)cobalt(II)] 1,2,4,5-benzenetetracarboxylate dihydrate, [Co2(C10H8N2)2(H2O)6(C10H2O8)] · 2H2O
Authors: Hu M.-L. , Ye M.-D. , Xiao H.-P. , Yuan J.-X. 
Published: September 2014

Abstract C30H34Co2N4O16, monoclinic, P121/n1 (no. 14), a = 12.286(1) Å, b = 7.5947(7) Å, c = 17.925(2) Å, β = 100.007(2)°, V = 1647.1 Å3, Z = 2, Rgt(F) = 0.025, wRref(F2) = 0.064, T = 273 K.
Crystal structure of chlorido(phenylselenolato)bis(triphenylphosphine)- platinum(II) –benzene (1:1), Pt(C6H5Se)(C18H15P)2Cl · C6H6
Authors: Hannu-Kuure M.S. , Oilunkaniemi R. , Laitinen R. S. , Ahlgren M. 
Published: September 2014

Abstract C48H41ClP2PtSe, triclinic, P1̅(no. 2), a = 10.1598(2) Å, b = 13.8660(5) Å, c = 14.7308(3) Å, α = 79.595(1)°, β = 86.006(2)°, γ = 87.997(2)°, V = 2035.6 Å3, Z = 2, Rgt(F) = 0.029, wRref(F2) = 0.070, T = 150 K.
Crystal structure of a mixed dicalcium ferrite, Ca2Fe1.66V0.34O5
Authors: Harringer N. A. , Presslinger H. , Klepp K. O. 
Published: September 2014

Abstract Ca2Fe1.66O5V0.34, orthorhombic, Pnma (no. 62), a = 5.4171(6) Å, b = 14.774(4) Å, c = 5.584(2) Å, V = 446.9 Å3, Z = 4, Rgt(F) = 0.032, wRref(F) = 0.037, T = 294 K.
Crystal structure of (2RS,4SR,4aSR)-1-acetyl-2-(1-methylethyl)-4-hydroxy- 4-methyl-1,2,3,4,4a,7-hexahydroquinoline, C15H22NO2
Authors: Gross S. , Brüdgam I. , Hartl H. , Reißig H.-U. 
Published: September 2014

Abstract C15H22NO2, monoclinic, P121/c1 (no. 14), a = 9.644(1) Å, b = 8.750(1) Å, c = 16.666(2) Å, β = 103.733(2)°, V = 1366.1 Å3, Z = 4, Rgt(F) = 0.046, wRref(F2) = 0.146, T = 153 K.
Crystal structure of (μ2-1,4-cyclohexanedicarboxylato)(1,10-phenanthroline)- copper(II) monohydrate, Cu(C12H8N2)(C8H10O4) · H2O
Authors: Ma A.-Q. , Yu M.-X. , Zhu L.-G. 
Published: September 2014

Abstract C20H20CuN2O5, monoclinic, P121/c1 (no. 14), a = 8.965(3) Å, b = 19.797(7) Å, c = 10.440(4) Å, β = 101.780(6)°, V = 1813.9 Å3, Z = 4, Rgt(F) = 0.054, wRref(F2) = 0.109, T = 293 K.
Crystal structure of trithallium-pentabromopalladate(II), Tl3PdBr5
Authors: Heines P. , Duchâteau M. , Keller H.-L. 
Published: September 2014

Abstract Br5PdTl3, orthorhombic, Pbca (no. 61), a = 7.823(2) Å, b = 16.812(3) Å, c = 17.299(3) Å, V = 2275.1 Å3, Z = 8, Rgt(F) = 0.045, wRref(F2) = 0.057, T = 293 K.
Crystal structure of (O-ethyldithiocarbonato)(triphenylphosphine)gold(I), (C6H5)3PAu(S2COC4H9)
Authors: Ho S. Y. , Tiekink E. R. T. 
Published: September 2014

Abstract C23H24AuOPS2, monoclinic, C12/c1 (no. 15), a = 23.581(1) Å, b = 13.7153(8) Å, c = 17.182(1) Å, β = 125.554(1)°, V = 4521.2 Å3, Z = 8, Rgt(F) = 0.026, wRref(F2) = 0.062, T = 183 K.
Crystal structure of aquabis(4-methyl-5-formyl-imidazolfuranoylhydrazone)- (trinitrato)praseodymium(III) monohydrate, Pr(H2O)(C9H10O2N4)2(NO3)3·H2O
Authors: Haba P. M. , Gaye M. , Sall A. S. , Barry A. H. , Jouini T. 
Published: September 2014

Abstract C20H24N11O15Pr, monoclinic, P121/c1 (no. 14), a = 18.956(4) Å, b = 8.161(2) Å, c = 22.151(3) Å, β = 114.53(2)°, V = 3117.5 Å3, Z = 4, Rgt(F) = 0.025, wRref(F2) = 0.063, T = 293 K.
Crystal structure of diaqua-bis(pyridine-2,6-dicarboxylato-O,N,O′)-(μ2- pyrazino)dicopper(II) dihydrate, [Cu2(C4H4N2)(C7H3NO4)2(H2O)2] · 2H2O
Authors: Altin E. , Kirchmaier R. , Lentz A. 
Published: September 2014

Abstract C18H18Cu2N4O12, monoclinic, P121/n1 (no. 14), a = 5.808(1) Å, b = 15.541(3) Å, c = 11.962(3) Å, β = 92.79(3)°, V = 1078.3 Å3, Z = 2, Rgt(F) = 0.028, wRref(F2) = 0.079, T = 293 K.
Crystal structure of dimethyl 1-acetyl-1,2-dihydro-2,3-quinolinedicarboxylate, C15H15NO5
Authors: Ramazani A. , Dolatyari L. , Kazemizadeh A. R. , Souldozi A. 
Published: September 2014

Abstract C15H15NO5, triclinic, P1̅ (no. 2), a = 7.366(1) Å, b = 8.884(2) Å, c = 11.242(2) Å, α = 68.640(4)°, β = 81.328(4)°, γ = 85.050(4)°, V = 676.9 Å3, Z = 2, Rgt(F) = 0.064, wRref(F2) = 0.151, T = 120 K.
Crystal structure of 2-(6-[2-(5-ethyl-5-hydroxy-6-methyl-tetrahydro-pyran- 2-yl)-15-oxo-2,10,12-trimethyl-1,6,8-trioxa-dispiro[4.1.5.3]pentadec-13-en- 9-yl]-2-hydroxy-1,3-dimethyl-4-oxo-heptyl-5-methyl-tetrahydro-pyran- 2-yl)-butyrate sodium, Na(C42H67O11), SY-9 – antibiotic 20-oxo-salinomycin
Authors: Paulus E. F. , Vértesy L. 
Published: September 2014

Abstract C42H67NaO11, orthorhombic, P212121 (no. 19), a = 10.5617(5) Å, b = 19.1580(9) Å, c = 21.5366(9) Å, V = 4357.7 Å3, Z = 4, Rgt(F) = 0.035, wRref(F2) = 0.082, T = 293 K.
Crystal structure of samarium nickel tetraaluminide, SmNiAl4
Authors: Fornasini M. L. , Raggio R. , Borzone G. 
Published: September 2014

Abstract Al4NiSm, orthorhombic, Cmcm (no. 63), a = 4.0948(6) Å, b = 15.582(3) Å, c = 6.610(1) Å, V = 421.8 Å3, Z = 4, Rgt(F) = 0.028, wRobs(F2) = 0.074, T = 293 K.
Crystal structure of pentabismuth heptaoxide nitrate, Bi5O7NO3
Authors: Ziegler P. , Ströbele M. , Meyer H.-J. 
Published: September 2014

Abstract Bi5NO10, monoclinic, P121/c1 (no. 14), a = 8.5846(6) Å, b = 23.385(2) Å, c = 5.5422(4) Å, β = 108.103(8)°, V = 1057.5 Å3, Z = 4, Rgt(F) = 0.029, wRref(F2) = 0.074, T = 210 K.
Crystal structure of bis(diaqua-μ-(4,4'-bipyridine-κN)bis(pyridine-2,6- dicarboxylato-κ 3O,N,O)dicopper(II)) monoaqua-μ-(4,4'-bipyridine-κN)- bis(pyridine-2,6-dicarboxylato-κ 3O,N,O)dicopper(II) hexahydrate, 2Cu2(H2O)2(C10H8N2)(C7H3NO4)2 · Cu2(H2O)(C10H8N2)(C7H3NO4)2 · 6H2O
Authors: Wen Y.-H. , He Y.-H. 
Published: September 2014

AbstractC72H64Cu6N12O35, triclinic, P1̅ (no. 2), a = 10.5798(5) Å, b = 10.7076(5) Å, c = 18.6826(6) Å, α = 84.413(7)°, β = 86.541(8)°, ϒ = 62.797(4)°, V = 1873.1 Å3, Z = 1, Rgt(F) = 0.029, wRref(F2) = 0.087, T = 130 K.
Crystal structure of cis-4-tert-butyl-2-(4-nitrophenylsulfonyl)cyclohexanone, C16H21NO5S
Authors: Zukerman-Schpector J. , Maganhi S. , Olivato P. R. , Vinhato E. , Cerqueira Jr. C. R. 
Published: September 2014

AbstractC16H21NO5S, triclinic, P1̅ (no. 2), a = 7.3395(9) Å, b = 11.103(1) Å, c = 11.391(1) Å, α = 107.933(9)°, β = 95.12(1)°, ϒ = 99.96(1)°, V = 859.8 Å3, Z = 2, Rgt(F) = 0.062, wRref(F2) = 0.218, T = 293 K.
Crystal structure of 1,3-benzene-bis(1-ferrocenyl-3-hydroxyprop-2-en-1-one), (C5H5)Fe(C22H16O4)Fe(C5H5)
Authors: Shi Y.-C. , Cheng H.-J. , Zhou R. , Lu Y. 
Published: September 2014

AbstractC32H26Fe2O4, monoclinic, C12/c1 (no. 15), a = 19.831(4) Å, b = 9.994(2) Å, c = 25.913(5) Å, β = 94.38(3)°, V = 5120.7 Å3, Z = 8, Rgt(F) = 0.053, wRref(F2) = 0.148, T = 295 K.
Crystal structure of N,N'-bis(4-nitrophenyl)-1,4-naphthalenedicarboxamide bis(dimethylsulfoxide) solvate, C24H16N4O6 · 2C2H6OS
Authors: Jing L.-H. , Qin D.-B. , Gu S.-J. , Zhang H.-X. , Mao Z.-H. 
Published: September 2014

AbstractC28H28N4O8S2, monoclinic, I12/a1 (no. 15), a = 23.820(5) Å, b = 9.166(3) Å, c = 26.778(6) Å, β = 95.58(2)°, V = 5818.9 Å3, Z = 8, Rgt(F) = 0.069, wRref(F2) = 0.176, T = 290 K.
Crystal structure of 4-methyl-N-(4,5-diazafluorenylidene)benzenamine monohydrate, C18H13N3 · H2O
Authors: Wang C.-X. , Wang P. , Li Z.-F. 
Published: September 2014

AbstractC18H15N3O, triclinic, P1̅ (no. 2), a = 7.624(2) Å, b = 8.626(2) Å, c = 11.086(2) Å, α = 77.68(3)°, β = 86.66(3)°, ϒ = 86.49(3)°, V = 710.2 Å3, Z = 2, Rgt(F) = 0.088, wRref(F2) = 0.156, T = 293 K.
Crystal structure of (2RS)-2-bromomethyl-4,4-dimethyl-3,4-dihydro- 2H-pyrrole 1-oxide hemi(hydrobromide), C7H12BrNO · ½HBr
Authors: Frey W. , Gulla M. , Jäger V. 
Published: September 2014

AbstractC7H12.50Br1.50NO, monoclinic, C12/c1 (no. 15), a = 22.249(2) Å, b = 8.571(1) Å, c = 11.083(1) Å, β = 117.037(8)°, V = 1882.5 Å3, Z = 8, Rgt(F) = 0.043, wRref(F2) = 0.116, T = 293 K.
Crystal structure of diaquabis(μ3-hydroxo)bis(μ2-hydroxo)- tetrakis(1,10-phenanthroline-N,N')tetracopper(II) tetraperchlorate tetrakis(N,N-dimethylformamide) solvate dihydrate, [Cu4(C12H8N2)4(OH)4(H2O)2][ClO4]4 · 4(CH3)2NCHO · 2H2O
Authors: Zhang G.-L. , Liu X.-F. , Liu W.-L. 
Published: September 2014

AbstractC60H72Cl4Cu4N12O28, triclinic, P1̅ (no. 2), a = 10.177(1) Å, b = 14.189(2) Å, c = 15.142(2) Å, α = 114.16(1)°, β = 92.98(1)°, ϒ = 109.77(1)°, V = 1830.7 Å3, Z = 1, Rgt(F) = 0.049, wRref(F2) = 0.155, T = 298 K.
Re-investigation of the crystal structure of dodecasodium dodecaniobomanganate( IV) hydrate (1:52), Na12[Mn(Nb6O19)2] · 52H2O
Authors: Wang J.-P. , Ma P.-T. , Niu J.-Y. 
Published: September 2014

Abstract H114MnNa6Nb12O92, monoclinic, P121/n1 (no. 14), a = 14.165(2) Å, b = 12.694(2) Å, c = 24.202(3) Å, β = 92.500(2)°, V = 4347.7 Å3, Z = 2, Rgt(F) = 0.030, wRref(F2) = 0.084, T = 293 K.
Crystal structure of tristrontium octagallide, Sr3-xGa8+3x (x = 0.15)
Authors: Haarmann F. , Prots Yu. , Göbel S. , von Schnering H. G. 
Published: September 2014

Abstract Ga8.45Sr2.85, orthorhombic, Immm (no. 71), a = 4.3958(9) Å, b = 4.5298(6) Å, c = 26.002(4) Å, V = 517.8 Å3, Z = 2, Rgt(F) = 0.038, wRref(F2) = 0.091, T = 293 K.
Crystal structure of dieuropium trigallium iridium, Eu2Ga3Ir
Authors: Sichevych O. , Prots Yu. , Schnelle W. , Schmidt M. , Grin Yu. 
Published: September 2014

Abstract Eu2Ga3Ir, hexagonal, P63/mmc (no. 194), a = 5.6785(2) Å, c = 8.6911(5) Å, V = 242.7 Å3, Z = 2, Rgt(F) = 0.032, wRref(F) = 0.028, T = 293 K.
Re-investigation of the crystal structure of trieuropium octagallide, Eu3-xGa8+3x (x = 0.12)
Authors: Sichevych O. , Prots Yu. , Grin Yu. 
Published: September 2014

Abstract Eu2.88Ga8.36, orthorhombic, Immm (no. 71), a = 4.4105(3) Å, b = 4.3732(2) Å, c = 25.852(1) Å, V = 498.6 Å3, Z = 2, Rgt(F) = 0.025, wRref(F) = 0.062, T = 295 K.
Crystal structure of niobium chromium nickel, Nb(Cr1-xNix)2 (x = 0.49)
Authors: Grüner D. , Ormeci A. , Kreiner G. 
Published: September 2014

Abstract Cr1.02NbNi0.98, hexagonal, P63/mmc (no. 194), a = 4.8692(5) Å, c = 7.9628(8) Å, V = 163.5 Å3, Z = 4, Rgt(F) = 0.052, wRref(F2) = 0.111, T = 293 K.
Crystal structure of (2,6-diisopropyl-phenyl)[N-tris(pentafluorophenyl)- boronyl-pyridin-2-yl]amine, (C6F5)3B(C5H4N)(C12H18N)
Authors: Noor A. , Irrgang T. , Kempe R. 
Published: September 2014

Abstract C35H22BF15N2, triclinic, P1̅ (no. 2), a = 9.800(1) Å, b = 12.022(1) Å, c = 14.326(1) Å, α = 99.486(5)°, β = 102.673(5)°, γ = 94.591(5)°, V = 1612.3 Å3, Z = 2, Rgt(F) = 0.046, wRref(F2) = 0.124, T = 193 K.
Crystal structure of bis(6,6-dimethylcyclohexadienyl)vanadium, V(C8H11)2
Authors: Ernst R. D. , Basta R. , Arif A. M. 
Published: September 2014

Abstract C16H22V, monoclinic, P121/a1 (no. 14), a = 12.1600(3) Å, b = 9.0848(3) Å, c = 13.2123(4) Å, β = 104.822(2)°, V = 1411.0 Å3, Z = 4, Rgt(F) = 0.046, wRref(F2) = 0.110, T = 200 K.
Crystal structure of 2-bromobenzoic acid hydrazide, C7H7BrN2O
Authors: Zareef M. , Iqbal R. , Qadeer G. , Wong W.-Y. , Akhtar H. , Arfan M. 
Published: September 2014

Abstract C7H7BrN2O, monoclinic, P121/c1 (no. 14), a = 12.769(3) Å, b = 12.754(3) Å, c = 5.026(1) Å, β = 99.874(4)°, V = 806.5 Å3, Z = 4, Rgt(F) = 0.028, wRref(F2) = 0.074, T = 293 K.
Crystal structure of 2-phenylsulfinyl-cyclohexanone, C12H14O2S
Authors: Zukerman-Schpector J. , Oliveira da Silva R. , Olivato P. R. , Vinhato E. , Rodrigues A. , Cerqueira C. R. 
Published: September 2014

Abstract C12H14O2S, monoclinic, P121/a1 (no. 14), a = 10.787(1) Å, b = 10.3955(9) Å, c = 10.888(1) Å, β = 108.928(5)°, V = 1154.9 Å3, Z = 4, Rgt(F) = 0.047, wRref(F2) = 0.142, T = 293 K.
Refinement of the crystal structure of bis(2-hydroxy-1,10- phenanthroline)dicopper(I), Cu2(C12H7N2O)2
Authors: Yu L. , Ma P.-T. , Li J. , Wang J.-P. 
Published: September 2014

Abstract C24H14Cu2N4O2, monoclinic, P121/n1 (no. 14), a = 4.7747(4) Å, b = 12.688(1) Å, c = 15.446(1) Å, β = 95.316(1)°, V = 931.7 Å3, Z = 2, Rgt(F) = 0.023, wRref(F2) = 0.062, T = 293 K.
Crystal structure of rel-(3aR,4S,6aS)-4-chloromethyl-6-methyl-3,6adiphenyl- 3a,4,6,6a-tetrahydro-isoxazolo[5,4-c]isoxazole, C18H17ClN2O2
Authors: Frey W. , Shiva S. , Jäger V. 
Published: September 2014

Abstract C18H17ClN2O2, monoclinic, P121/c1 (no. 14), a = 12.2900(9) Å, b = 13.325(1) Å, c = 10.482(1) Å, β = 102.69(1)°, V = 1674.7 Å3, Z = 4, Rgt(F) = 0.053, wRref(F2) = 0.162, T = 293 K.
Crystal structure of 6-(4-difluoromethoxy-3-methoxyphenyl)-3(2H)- pyridazinone, C12H10F2N2O3
Authors: Doyle C. R. , Zimmerman M. D. , Chruszcz M. , Cymborowski M. , Gawlicka-Chruszcz A. , Minor W. 
Published: September 2014

Abstract C12H10F2N2O3, monoclinic, P121/n1 (no. 14), a = 7.239(1) Å, b = 15.838(1) Å, c = 10.099(1) Å, β = 91.991(6)°, V = 1157.2 Å3, Z = 4, Rgt(F) = 0.033, wRref(F2) = 0.093, T = 109 K.
Refinement of the crystal structure of sinoacutine, C19H21NO4
Authors: Wang X.-L. 
Published: September 2014

Abstract C19H21NO4, orthorhombic, P212121 (no. 19), a = 10.817(2) Å, b = 11.463(2) Å, c = 13.025(2) Å, V = 1615.0 Å3, Z = 4, Rgt(F) = 0.038, wRref(F2) = 0.083, T = 297 K.
Crystal structure of tetraaqua-bis(norfloxacin)barium(II) 1,4-benzenedicarboxylate hydrate, [Ba(H2O)4(C16H17FN3O3)2][C6H4(COO)2] · H2O
Authors: An Z. , Wang R.-S. 
Published: September 2014

Abstract C40H48BaF2N6O15, triclinic, P1̅ (no. 2), a = 12.305(1) Å, b = 12.472(1) Å, c = 16.591(2) Å, α = 101.920(2)°, β = 104.630(2)°, γ = 111.703(1)°, V = 2157.9 Å3, Z = 2, Rgt(F) = 0.054, wRref(F2) = 0.170, T = 295 K.
Crystal structure of catena-[dodecaaqua(μ3-benzene-1,3,5-tricarboxylato)- (μ2-benzene-1,3,5-tricarboxylato)tricopper(II)], Cu3(H2O)12(C9H3O6)2
Authors: Zhang Q.-W. , Wang G.-X. 
Published: September 2014

Abstract C18H30Cu3O24, monoclinic, C121 (no. 5), a = 17.412(2) Å, b = 12.913(3) Å, c = 6.5669(1) Å, β = 111.93(2)°, V = 1369.7 Å3, Z = 2, Rgt(F) = 0.036, wRref(F2) = 0.083, T = 293 K.
Crystal structure of 1,6-bis(1-phenyl-1H-tetrazol-5-ylthio)hexane, C6H12(SCN4C6H5)2
Authors: He D.-P. , Dou Y.-L. , She J.-B. 
Published: September 2014

Abstract C20H22N8S2, monoclinic, P121/c1 (no. 14), a = 7.481(4) Å, b = 16.759(9) Å, c = 8.621(5) Å, β = 101.555(8)°, V = 1059.0 Å3, Z = 2, Rgt(F) = 0.038, wRref(F2) = 0.096, T = 298 K.
Crystal structure of trans-bis(triphenylphospine oxide)tetrachlorotitanum( IV), TiCl4[(C6H5)3PO]2
Authors: Li M.-F. , Shan Y.-K. 
Published: September 2014

Abstract C36H30Cl4O2P2Ti, triclinic, P1̅ (no. 2), a = 9.492(1) Å, b = 9.640(1) Å, c = 10.429(1) Å, α = 102.100(2)°, β = 108.657(2)°, γ = 92.652(2)°, V = 877.4 Å3, Z = 1, Rgt(F) = 0.043, wRref(F2) = 0.106, T = 273 K.
Crystal structure of (R)-1,1′-bi-2-naphthol 1,3-bis(pyrid-4-yl)propane, C20H14O2 · C13H14N2
Authors: Ma Z.-C. 
Published: September 2014

Abstract C33H28N2O2, orthorhombic, P212121 (no. 19), a = 10.106(1) Å, b = 11.501(1) Å, c = 22.425(2) Å, V = 2606.4 Å3, Z = 4, Rgt(F) = 0.062, wRref(F2) = 0.124, T = 298 K.
Pleiotropic roles of Notch signaling in normal, malignant, and developmental hematopoiesis in the human
Authors: Kushwah Rahul , Guezguez Borhane , Lee Jung Bok , Hopkins Claudia I , Bhatia Mickie 
Published: September 2014

AbstractThe Notch signaling pathway is evolutionarily conserved across species and plays an important role in regulating cell differentiation, proliferation, and survival. It has been implicated in several different hematopoietic processes including early hematopoietic development as well as adult hematological malignancies in humans. This review focuses on recent developments in understanding the role of Notch signaling in the human hematopoietic system with an emphasis on hematopoietic initiation from human pluripotent stem cells and regulation within the bone marrow. Based on recent insights, we summarize potential strategies for treatment of human hematological malignancies toward the concept of targeting Notch signaling for fate regulation.
Die Abgrenzung zwischen bezweckten und bewirkten Wettbewerbsbeschränkungen nach Art. 101 AEUV
Authors: Kuhn Tilman 
Published: September 2014

Zusammenfassung
Die Grenzlinien zwischen i. S. d. Art. 101 Abs. 1 AEUV bezweckten und bewirkten Wettbewerbsbeschränkungen verschwimmen zunehmend. Gerade in den letzten Jahren wurden neue Formen von Beschränkungen, die keine klassischen Kernbeschränkungen darstellten, von der Europäischen Kommission und den Unionsgerichten als bezweckte Beschränkungen eingestuft. In den USA werden hingegen immer weniger Arten von Beschränkungen als per se verboten angesehen. Der Verfasser analysiert insbesondere das jüngere Fallrecht und die offenen Fragestellungen zum Konzept der bezweckten Wettbewerbsbeschränkung im EU-Recht, die praktische Bedeutung der Abgrenzung zwischen bezweckten und bewirkten Wettbewerbsbeschränkungen, und plädiert für klarere Grenzlinien.
An Improved Genetic Algorithm for the Multi Level Uncapacitated Facility Location Problem
Authors: Korac Vanja Miomir , Kratica Jozef , Savić Aleksandar 
Published: September 2014

In this paper, an improved genetic algorithm (GA) for solving the multi-level uncapacitated facility location problem (MLUFLP) is presented. First improvement is achieved by better implementation of dynamic programming, which speeds up the running time of the overall GA implementation. Second improvement is hybridization of the genetic algorithm with the fast local search procedure designed specially for MLUFLP. The experiments were carried out on instances proposed in the literature which are modied standard single level facility location problem instances. Improved genetic algorithm reaches all known optimal and the best solutions from literature, but in much shorter time. Hybridization with local search improves several best-known solutions for large-scale MLUFLP instances, in cases when the optimal is not known. Overall running time of both proposed GA methods is signicantly shorter compared to previous GA approach.
Modeling and Simulation of Genetic Fuzzy Controller for L-type ZCS Quasi-Resonant Converter
Authors: Ranjani Mani , Murugesan Palzha 
Published: September 2014

A new method of speed control of DC drives using series Quasi-Resonant (QR) Zero current switching (ZCS)DC to DC converters is proposed. .It employs a Fuzzy logic controller (FLC) in feed back loop conventionally but due to the advent of new intelligent techniques the FLC are optimized by Genetic algorithm (GA). In this paper the GA optimization technique is applied for speed control of series ZCS-QRC fed drive. The main objective of this work is to obtain reduced transient response, reduced switching stresses and switching losses which in turn enhances the efficiency and commutation capability of motor